期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 24, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/ijms24032822
关键词
Nocardiopsis sp; sphydrofuran derivatives; structure elucidation; lipid-lowering
Lipid-lowering is an effective method for preventing and treating cardiovascular diseases, and developing safe and effective novel lipid-lowering drugs is of great significance. We discovered that the organic crude extracts of Nocardiopsis sp. ZHD001 exhibited strong lipid-lowering effects in high-fat-diet-fed mice models. Chemical investigations led to the identification of two new sphydrofuran-derived compounds and one known compound. Bioactivity evaluations showed that these compounds exhibited significant lipid-lowering activity with lower cytotoxicity compared to simvastatin. Our results suggest that sphydrofuran-derived compounds may be promising candidates for lipid-lowering drugs.
Lipid-lowering is one of the most effective methods of prevention and treatment for cardiovascular diseases. However, most clinical lipid-lowering drugs have adverse effects and cannot achieve the desired efficacy in some complex hyperlipidemia patients, so it is of great significance to develop safe and effective novel lipid-lowering drugs. In the course of our project aimed at discovering the chemical novelty and bioactive natural products of marine-derived actinomycetes, we found that the organic crude extracts (OCEs) of Nocardiopsis sp. ZHD001 exhibited strong in vivo efficacies in reducing weight gain, lowering LDL-C, TC, and TG levels, and improving HDL-C levels in high-fat-diet-fed mice models. Chemical investigations of the active OCEs led to identifying two new sphydrofuran-derived compounds (1-2) and one known 2-methyl-4-(1-glycerol)-furan (3). Their structures were elucidated by the analysis of HRESIMS, 1D and 2D NMR spectroscopic data, and ECD calculations. Among these compounds, compound 1 represents a novel rearranged sphydrofuran-derived derivative. Bioactivity evaluations of these pure compounds showed that all the compounds exhibited significant lipid-lowering activity with lower cytotoxicity in vitro compared to simvastatin. Our results demonstrate that sphydrofuran-derived derivatives might be promising candidates for lipid-lowering drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据